BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Teva
Merck
Express Scripts
Chubb
Accenture
Cerilliant
Covington
Moodys

Generated: January 22, 2018

DrugPatentWatch Database Preview

Chlorpheniramine maleate; pseudoephedrine sulfate - Generic Drug Details

« Back to Dashboard

What are the generic sources for chlorpheniramine maleate; pseudoephedrine sulfate and what is the scope of chlorpheniramine maleate; pseudoephedrine sulfate patent protection?

Chlorpheniramine maleate; pseudoephedrine sulfate
is the generic ingredient in one branded drug marketed by Bayer Healthcare Llc and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are twenty-nine drug master file entries for chlorpheniramine maleate; pseudoephedrine sulfate.
Summary for chlorpheniramine maleate; pseudoephedrine sulfate

US Patents and Regulatory Information for chlorpheniramine maleate; pseudoephedrine sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Healthcare Llc CHLOR-TRIMETON chlorpheniramine maleate; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 018397-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Julphar
US Department of Justice
Mallinckrodt
AstraZeneca
Federal Trade Commission
Express Scripts
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot